Sandercock Brett
SEC CIK 1346064 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RMD | ResMed| | CFO | 83.5K | — | $33.06M | 68 | 2021-07-12 | 2026-04-01 |
Most active insiders at RMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farrell Michael J. | COB, CEO, Dir | — | $15.74M |
| 2 | FARRELL PETER C | Dir | — | $5.01M |
| 3 | Sandercock Brett | CFO | — | $2.79M |
| 4 | De Witte Jan | Dir | — | $645.9K |
| 5 | Rider Michael J | Gbl GC | — | $64.7K |
| 6 | Mowad-Nassar Nicole | Dir | — | — |
| 7 | Hernandez John | Dir | — | — |
| 8 | Tan Desney | Dir | — | — |
| 9 | DelOrefice Christopher | Dir | — | — |
| 10 | Leong Justin | Chief Product Off | — | — |
Transactions 68
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-03 07:29 | 2026-04-01 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $224.31 | -1,000 | 83.5K | -1% | -$224.3K |
| 2026-03-03 | 2026-03-02 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $254.30 | -1,000 | 84.5K | -1% | -$254.3K | |
| 2026-02-03 | 2026-02-02 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $257.03 | -1,000 | 85.5K | -1% | -$257.0K | |
| 2026-01-05 | 2026-01-02 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $241.75 | -1,000 | 86.5K | -1% | -$241.8K | |
| 2025-12-02 | 2025-12-01 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $244.16 | -1,000 | 87.5K | -1% | -$244.2K | |
| 2025-11-24 | 2025-11-20 | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $0.00 | +2,710 | 88.5K | +3% | $0 | |
| D | 2025-11-04 | 2025-11-03 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $101.64 | +2,000 | 88.7K | +2% | +$203.3K |
| D | 2025-11-04 | 2025-11-03 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $247.54 | -3,000 | 85.7K | -3% | -$742.6K |
| D | 2025-10-03 | 2025-10-01 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $101.64 | +2,000 | 89.7K | +2% | +$203.3K |
| D | 2025-10-03 | 2025-10-01 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $274.36 | -3,000 | 86.7K | -3% | -$823.1K |
| D | 2025-09-03 | 2025-09-02 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $101.64 | +2,000 | 90.7K | +2% | +$203.3K |
| D | 2025-09-03 | 2025-09-02 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $270.77 | -3,000 | 87.7K | -3% | -$812.3K |
| 2025-08-19 | 2025-08-15 | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $0.00 | +5,462 | 88.7K | +7% | $0 | |
| D | 2025-08-05 | 2025-08-01 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $281.90 | -3,000 | 83.3K | -3% | -$845.7K |
| D | 2025-08-05 | 2025-08-01 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $101.64 | +2,000 | 86.3K | +2% | +$203.3K |
| DM | 2025-07-02 | 2025-07-01 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $101.64 | +2,883 | 88.2K | +3% | +$293.0K |
| D | 2025-07-02 | 2025-07-01 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $256.99 | -3,883 | 84.3K | -4% | -$997.9K |
| 2025-06-03 | 2025-06-02 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $243.78 | -1,000 | 85.3K | -1% | -$243.8K | |
| 2025-05-27 | 2025-05-22 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $244.59 | -3,644 | 86.3K | -4% | -$891.3K | |
| 2025-04-10 | 2025-04-08 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $215.58 | -1,000 | 89.9K | -1% | -$215.6K | |
| 2025-03-11 | 2025-03-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $230.36 | -1,000 | 90.9K | -1% | -$230.4K | |
| 2025-02-11 | 2025-02-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $238.98 | -1,000 | 91.9K | -1% | -$239.0K | |
| 2025-01-10 | 2025-01-08 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $234.04 | -1,000 | 92.9K | -1% | -$234.0K | |
| 2024-12-11 | 2024-12-09 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $244.23 | -1,000 | 93.9K | -1% | -$244.2K | |
| 2024-11-12 | 2024-11-08 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $249.00 | -1,000 | 94.9K | -1% | -$249.0K | |
| 2024-10-09 | 2024-10-08 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $233.47 | -1,000 | 95.8K | -1% | -$233.5K | |
| 2024-09-10 | 2024-09-09 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $246.42 | -1,000 | 96.8K | -1% | -$246.4K | |
| M | 2024-08-16 | 2024-08-15 | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $0.00 | +8,756 | 97.8K | +10% | $0 |
| 2024-08-12 | 2024-08-08 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $212.16 | -1,000 | 89.1K | -1% | -$212.2K | |
| 2024-07-09 | 2024-07-08 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $194.35 | -1,000 | 90.1K | -1% | -$194.3K | |
| 2024-06-11 | 2024-06-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $209.81 | -1,000 | 91.1K | -1% | -$209.8K | |
| D | 2024-05-10 | 2024-05-08 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $101.64 | +12.0K | 105.1K | +13% | +$1.22M |
| D | 2024-05-10 | 2024-05-08 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $211.37 | -13.0K | 92.1K | -12% | -$2.75M |
| 2023-11-29 | 2023-11-27 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $152.62 | -3,000 | 93.0K | -3% | -$457.9K | |
| 2023-08-18 | 2023-08-17 | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $0.00 | +4,972 | 95.9K | +5% | $0 | |
| 2023-05-12 | 2023-05-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $233.13 | -12.6K | 90.9K | -12% | -$2.93M | |
| 2023-05-10 | 2023-05-09 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $232.05 | -3,426 | 103.5K | -3% | -$795.0K | |
| 2023-02-22 | 2023-02-17 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $215.22 | -10.0K | 106.9K | -9% | -$2.15M | |
| 2023-02-14 | 2023-02-13 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $215.00 | -4,000 | 116.9K | -3% | -$860.0K | |
| 2022-11-23 | 2022-11-23 | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $0.00 | +14.6K | 120.9K | +14% | $0 | |
| 2022-11-09 | 2022-11-07 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $212.02 | -4,000 | 106.3K | -4% | -$848.1K | |
| 2022-08-22 | 2022-08-18 | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $0.00 | +3,847 | 110.3K | +4% | $0 | |
| D | 2022-08-12 | 2022-08-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $240.66 | -2,500 | 106.4K | -2% | -$601.6K |
| D | 2022-08-12 | 2022-08-10 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 108.9K | +2% | +$144.4K |
| D | 2022-07-26 | 2022-07-22 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $235.00 | -7,500 | 106.4K | -7% | -$1.76M |
| DM | 2022-07-26 | 2022-07-22 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +7,500 | 108.9K | +7% | +$433.2K |
| D | 2022-04-12 | 2022-04-11 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $247.00 | -2,500 | 106.4K | -2% | -$617.5K |
| D | 2022-04-12 | 2022-04-11 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 108.9K | +2% | +$144.4K |
| D | 2022-03-14 | 2022-03-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $241.29 | -2,500 | 106.4K | -2% | -$603.2K |
| D | 2022-03-14 | 2022-03-10 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 108.9K | +2% | +$144.4K |
| D | 2022-02-14 | 2022-02-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $241.86 | -2,500 | 106.4K | -2% | -$604.6K |
| D | 2022-02-14 | 2022-02-10 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 108.9K | +2% | +$144.4K |
| D | 2022-01-11 | 2022-01-10 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 108.9K | +2% | +$144.4K |
| D | 2022-01-11 | 2022-01-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $235.00 | -2,500 | 106.4K | -2% | -$587.5K |
| D | 2021-12-14 | 2021-12-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $264.92 | -2,500 | 106.4K | -2% | -$662.3K |
| D | 2021-12-14 | 2021-12-10 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 108.9K | +2% | +$144.4K |
| M | 2021-11-18 | 2021-11-16+ | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $241.06 | +21.5K | 106.4K | +25% | +$5.19M |
| D | 2021-11-12 | 2021-11-10 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 87.3K | +3% | +$144.4K |
| D | 2021-11-12 | 2021-11-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $260.58 | -2,500 | 84.8K | -3% | -$651.5K |
| D | 2021-10-12 | 2021-10-11 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 89.8K | +3% | +$144.4K |
| D | 2021-10-12 | 2021-10-11 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $253.37 | -5,000 | 84.8K | -6% | -$1.27M |
| D | 2021-09-13 | 2021-09-10 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 92.3K | +3% | +$144.4K |
| D | 2021-09-13 | 2021-09-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $297.33 | -5,000 | 87.3K | -5% | -$1.49M |
| DM | 2021-08-23 | 2021-08-20 | RMD | ResMed| | Sandercock Brett | CFO | M - OptEx | $57.76 | +10.7K | 95.0K | +13% | +$620.1K |
| D | 2021-08-23 | 2021-08-20 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale+OE | $281.73 | -10.7K | 89.8K | -11% | -$3.02M |
| 2021-08-20 | 2021-08-19 | RMD | ResMed| | Sandercock Brett | CFO | A - Grant | $0.00 | +4,784 | 89.8K | +6% | $0 | |
| 2021-08-11 | 2021-08-10 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $278.05 | -2,500 | 85.0K | -3% | -$695.1K | |
| 2021-07-13 | 2021-07-12 | RMD | ResMed| | Sandercock Brett | CFO | S - Sale | $248.46 | -2,500 | 87.5K | -3% | -$621.1K |
Purchase Sale Sale after option exercise All abbreviations